相关实验视频
Updated: Jan 29, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.7K
血清生长差异化因子8 (肌静素) 度在患有早期慢性病的猫群中
Kerrigan Fleming1, William H Whitehouse1
1Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA.
Veterinary sciences
|January 28, 2026
概括
血清生长分化因子8 (GDF8) 水平在患有早期慢性病 (CKD) 的猫身上没有升高. 在患有CKD的猫中,GDF8度与肌肉状况得分和年龄相关.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 慢性病 (CKD) 与体重减轻有关,即使是在早期阶段.
- 人类CKD患者的生长分化因子8 (GDF8),肌肉生长的负调节剂,在人体CKD患者中升高.
- 升高的GDF8可能会导致CKD的肌肉消耗.
研究的目的:
- 为了研究早期CKD的猫的血清GDF8度.
- 为了比较健康的猫和IRIS阶段1和2CKD的猫之间的GDF8水平.
- 探索GDF8和CKD猫的临床参数之间的关联.
主要方法:
- 从健康的猫 (n=10) 和患有IRIS第一阶段 (n=5) 和第二阶段 (n=10) 的CKD的猫收集了血清样本.
- 使用三明治ELISA测量血清GDF8度.
- 分析了GDF8与年龄,性别,体重,BCS,MCS和脏参数之间的相关性.
主要成果:
- 在健康猫,IRIS第一阶段CKD猫和IRIS第二阶段CKD猫中,血清GDF8度没有显著差异.
- GDF8显示了与肌肉状况得分 (MCS) 的中度正相关性.
- GDF8表明与年龄的反向相关性.
结论:
- 血清GDF8在患有CKD早期阶段的猫身上没有升高.
- 猫的GDF8水平可能与肌肉质量和年龄有关,独立于早期的CKD.
- 需要进一步的研究来了解GDF8在猫类CKD进展和肌肉健康中的作用.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
702
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
702
01:24Chronic Kidney Disease II: Clinical Manifestations
617
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
617
01:28Chronic Kidney Disease III: Interprofessional Care
390
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
390
01:18Chronic Kidney Disease IV: Nursing Management
368
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
368
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
207
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
207
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
205
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
205